Lantern Pharma Announces Pricing of $60 Million Public Offering
DALLAS, Jan. 14, 2021 /PRNewswire/ — Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR® artificial intelligence («A.I.»)…
DALLAS, Jan. 14, 2021 /PRNewswire/ — Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR® artificial intelligence («A.I.»)…
SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Thoma Bravo Advantage (the «Company»), a newly incorporated blank check company incorporated as…
SEATTLE, Jan. 14, 2021 /PRNewswire/ — AltPep Corporation, a privately held biomedical company focused on diagnosing and treating Central Nervous System…
LAS VEGAS, Jan. 14, 2021 /PRNewswire/ — As Maier Gutierrez & Associates celebrates a decade in business as a boutique Las…
WASHINGTON, Jan. 14, 2021 /PRNewswire/ — Today, President-elect Joe Biden is releasing his plan for economic recovery from the coronavirus…
WASHINGTON, Jan. 14, 2021 /PRNewswire/ — Statement of Scott J. Knoer, executive vice president and CEO of the American Pharmacists…
NEW YORK, Jan. 14, 2021 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law…
WASHINGTON, Jan. 14, 2021 /PRNewswire/ — The American College of Emergency Physicians (ACEP) applauds the U.S. Department of Health and…
GRAND HAVEN, Mich., Jan. 14, 2021 /PRNewswire/ — UV Angel, maker of next generation pathogen control technology, today announced a…
BRENTWOOD, Tenn., Jan. 14, 2021 /PRNewswire/ — Delek US Holdings, Inc. (NYSE: DK) («Delek US» or the «Company») today issued…